Phase 2
Completed N=5
Hidradenitis Suppurativa Wound Care
Hidradenitis Suppurativa (HS)
Source: ClinicalTrials.gov NCT04354012 ↗
Enrolled (actual)
5
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcomePrimary: Percent Change in Wound Size — 57.2 percentage change in wound size
Summary
The objective of this case series is to monitor time and outcome of healing of wounds associated with HS using Endoform [ovine forestomach], Hydrofera Blue [methylene blue and gentian violet], and Hypafix tape. a combination methylene blue, gentian violet, and ovine forestomach wound care product.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Change in Wound Size |
57.2 | — |
| SECONDARY Change in Pain Assessment Scores |
3.12 | — |
Eligibility Criteria
Inclusion Criteria
- Individuals with hidradenitis suppurativa with non-healing wounds or draining abscesses/nodules
- Individuals over 18 years of age
Exclusion Criteria
- Individuals younger than 18 years of age
- Individuals without a diagnosis of HS
Data sourced from ClinicalTrials.gov (NCT04354012). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.